1. Hepatic PPARγ and LXRα independently regulate lipid accumulation in the livers of genetically obese mice.
- Author
-
Matsusue K, Aibara D, Hayafuchi R, Matsuo K, Takiguchi S, Gonzalez FJ, and Yamano S
- Subjects
- Animals, Anticholesteremic Agents pharmacology, Blood Glucose, Hydrocarbons, Fluorinated pharmacology, Hypoglycemic Agents pharmacology, Liver pathology, Liver X Receptors, Mice, Mice, Knockout, Mice, Obese, Orphan Nuclear Receptors agonists, Sulfonamides pharmacology, Fatty Liver metabolism, Lipogenesis, Liver metabolism, Orphan Nuclear Receptors physiology, PPAR gamma physiology
- Abstract
The nuclear hormone receptors liver X receptor α (LXRα) and peroxisome proliferator-activated receptor γ (PPARγ) play key roles in the development of fatty liver. To determine the link between hepatic PPARγ and LXRα signaling and the development of fatty liver, a LXRα-specific ligand, T0901317, was administered to normal OB/OB and genetically obese (ob/ob) mice lacking hepatic PPARγ (Pparγ(ΔH)). In ob/ob-Pparγ(ΔH) and OB/OB-Pparγ(ΔH) mice, as well as ob/ob-Pparγ(WT) and OB/OB-Pparγ(WT) mice, the liver weights and hepatic triglyceride levels were markedly increased in response to T0901317 treatment. These results suggest that hepatic PPARγ and LXRα signals independently contribute to the development of fatty liver., (Copyright © 2014 Federation of European Biochemical Societies. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF